ClearPoint Neuro, Inc. reaffirmed revenue guidance for the year 2022. The Company reaffirms its full year 2022 revenue outlook of between $21.0 and $22.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.52 USD | -1.25% |
|
+5.14% | -18.70% |
Jun. 20 | Clinical Laserthermia Systems Gets Additional SEK7.5 Million Orders from ClearPoint Neuro | MT |
Jun. 04 | ClearPoint Neuro, Inc. Initiates Its Full Market Release of the Smartframe | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.70% | 151M | |
+5.16% | 213B | |
+9.62% | 188B | |
+31.18% | 157B | |
+33.37% | 113B | |
+3.46% | 64.85B | |
+1.51% | 49.1B | |
-4.27% | 38.83B | |
+0.88% | 35.6B | |
+8.44% | 27.4B |
- Stock Market
- Equities
- CLPT Stock
- News ClearPoint Neuro, Inc.
- ClearPoint Neuro, Inc. Reaffirms Revenue Guidance for the Year 2022